AngioDynamics ANGO Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is AngioDynamics's investing cash flow?
- AngioDynamics (ANGO) reported investing cash flow of -$1.51M in Q4 2025.
- How has AngioDynamics's investing cash flow changed year-over-year?
- AngioDynamics's investing cash flow increased by 52.7% year-over-year, from -$3.19M to -$1.51M.
- What is the long-term trend for AngioDynamics's investing cash flow?
- Over 3 years (2021 to 2025), AngioDynamics's investing cash flow has grown at a -9.5% compound annual growth rate (CAGR), from -$13.71M to -$10.18M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.